AbbVie Inc. stock price

Today's NYSE:ABBV chart, history & news

Price:
108.22 USD
Change:
-0.03 (-0.03%)
Trade Buy
67% of retail CFD accounts lose money

Key stats

Price open 108.03
Previous close 108.25
Market cap 190.99B
Volume 6.16M
Day high 108.355
Day low 107.03
Year high 113.1
Year low 76.71
Year to date change 2.18%
P/E ratio 39.79
Company Profile
Fundamentals
Insider Information
News

About AbbVie Inc.

Founded in 2013, AbbVie is a biopharmaceutical company that discovers, develops, and sells pharmaceutical products. The company came into being following a split of Abbott Laboratories into two. The new Abbott went on to specialize in medical devices as well as diagnostic equipment while AbbVie transitioned into a biopharmaceutical company.

Headquartered in North Chicago, Illinois, the company operates as a research-based pharmaceutical company with a 30,000-employee base made up of scientist’s researchers, manufacturing specialists, and regulatory experts.

The company’s products treat conditions such as chronic autoimmune diseases, oncology, rheumatology, and dermatology. It’s lead products include Humira, a novel treatment for autoimmune conditions and intestinal Behcet’s diseases, and accounts for nearly half of the company’s drug division revenue. Imbruvica is the company’s novel treatment for chronic lymphocytic leukemia.

Divestiture of AbbVie from Abbott Laboratories resulted in its listing on the New York Stock Exchange in 2013.

Company information

Company name
AbbVie Inc.
Exchange
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Richard Gonzalez
Address
1 N Waukegan Rd, North Chicago, Illinois, 60064-1802
Country
United States
Contact information
18479327900
Website
https://www.abbvie.com/